FACIT
Tag
Jun 26, 2024
![New patient-centred system for brain cancer radiotherapy receives top honours at FACIT Falcons’ Fortunes](https://oicr.on.ca/wp-content/uploads/2024/06/DSC_0479-1-scaled.jpg)
New patient-centred system for brain cancer radiotherapy receives top honours at FACIT Falcons’ Fortunes
Dec 19, 2023
![New tech could modernize recovery from gynecological cancers](https://oicr.on.ca/wp-content/uploads/2023/12/HyIvy.jpg)
New tech could modernize recovery from gynecological cancers
Sep 27, 2023
![Wave of medical imaging innovation hits shores of Lake Superior](https://oicr.on.ca/wp-content/uploads/2023/09/minh-cao-PPJLC-wVhTs-unsplash.jpg)
Wave of medical imaging innovation hits shores of Lake Superior
Jun 07, 2023
![How Falcons’ Fortunes winner plans to stop colorectal cancer from coming back](https://oicr.on.ca/wp-content/uploads/2023/06/Sumi_resized-e1686169840386.jpg)
How Falcons’ Fortunes winner plans to stop colorectal cancer from coming back
Aug 08, 2022
![FACIT pitch competition empowers Ontario’s oncology entrepreneurs](https://oicr.on.ca/wp-content/uploads/2022/08/saumik-and-team-2-scaled.jpg)
FACIT pitch competition empowers Ontario’s oncology entrepreneurs
Apr 28, 2022
![Two OICR innovations bolstered by investments from FACIT](https://oicr.on.ca/wp-content/uploads/2022/04/The-Prospects-Fund-Logo_F_Colour.jpg)
Two OICR innovations bolstered by investments from FACIT
Jun 23, 2020
![FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund](https://oicr.on.ca/wp-content/uploads/2020/06/prospects-fund-news-release.jpg)
FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund
Jun 09, 2020
![FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)](https://oicr.on.ca/wp-content/uploads/2020/06/CVCA-Regional-Impact-Award.jpg)
FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)
Nov 06, 2019
![FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research](https://oicr.on.ca/wp-content/uploads/2019/11/facit-headshots.png)
FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research
Oct 30, 2019
![FACIT and University of Toronto launch precision medicine company: Cellular Analytics](https://oicr.on.ca/wp-content/uploads/2019/10/cellular-logo.jpg)
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
Sep 26, 2019
![FACIT's Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies](https://oicr.on.ca/wp-content/uploads/2017/02/OICR_FACIT.jpg)
FACIT's Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies
Jun 18, 2019
![From idea to impact: An expanding solution to a common surgical problem](https://oicr.on.ca/wp-content/uploads/2019/06/facit-winner-2019-1-SLawler.jpg)
From idea to impact: An expanding solution to a common surgical problem
Apr 09, 2019
![Entrepreneurs from Ontario's Nanology Labs and Xpan Inc. receive FACIT investment for early-stage cancer innovations ](https://oicr.on.ca/wp-content/uploads/2019/04/facit-daul-icon.jpg)
Entrepreneurs from Ontario's Nanology Labs and Xpan Inc. receive FACIT investment for early-stage cancer innovations
Mar 27, 2019
![The winner of last year’s FACIT Falcons’ Fortunes pitch competition is already seeing early success in moving her product to the clinic](https://oicr.on.ca/wp-content/uploads/2019/03/FACITv2.jpg)
The winner of last year’s FACIT Falcons’ Fortunes pitch competition is already seeing early success in moving her product to the clinic
Feb 07, 2019
![Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene](https://oicr.on.ca/wp-content/uploads/2019/02/rima5.jpg)
Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene
Jan 29, 2019
![FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
Jan 29, 2019
![First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment](https://oicr.on.ca/wp-content/uploads/2019/01/Rodan-OICR-012919-283-edit.jpg)
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
Jan 10, 2019
![FACIT makes follow-on investment in AI-based genomics company, DNAstack](https://oicr.on.ca/wp-content/uploads/2019/10/facit-logo.png)
FACIT makes follow-on investment in AI-based genomics company, DNAstack
Oct 11, 2018
![FACIT Welcomes Har Grover and Ken Lawless to the Board](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT Welcomes Har Grover and Ken Lawless to the Board
Sep 13, 2018
![FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
Aug 22, 2018
![Heliotrope: Personalizing cancer treatment decisions](https://oicr.on.ca/wp-content/uploads/2018/08/JustinCook.jpg)
Heliotrope: Personalizing cancer treatment decisions
Aug 02, 2018
![Ontario centre attracts national attention for probe research, development and commercialization](https://oicr.on.ca/wp-content/uploads/2018/08/CPDC.jpg)
Ontario centre attracts national attention for probe research, development and commercialization
Jun 27, 2018
![Healthcare Software Start-Up Ziliomics Financed by FACIT](https://oicr.on.ca/wp-content/uploads/2019/10/facit-logo.png)
Healthcare Software Start-Up Ziliomics Financed by FACIT
Jun 13, 2018
![FACIT Appoints Biotech Veteran Dr. David O'Neill as President](https://oicr.on.ca/wp-content/uploads/2019/12/David-ONeill.jpg)
FACIT Appoints Biotech Veteran Dr. David O'Neill as President
Apr 12, 2018
![Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition](https://oicr.on.ca/wp-content/uploads/2019/03/FACITv2.jpg)
Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
Feb 21, 2018
![FACIT invests $450k in promising Ontario breakthrough technologies](https://oicr.on.ca/wp-content/uploads/2016/05/facit-feature.jpg)
FACIT invests $450k in promising Ontario breakthrough technologies
Dec 04, 2017
![OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic](https://oicr.on.ca/wp-content/uploads/2017/11/ctip-thumb.jpg)
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Nov 22, 2017
![FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees](https://oicr.on.ca/wp-content/uploads/2016/05/facit-feature.jpg)
FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees
Oct 04, 2017
![FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A](https://oicr.on.ca/wp-content/uploads/2016/03/fusion.jpg)
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
Sep 29, 2017
![OICR 2016/17 Annual Report](https://oicr.on.ca/wp-content/uploads/2017/09/AnnualReportCover.jpg)
OICR 2016/17 Annual Report
Aug 01, 2017
![FACIT launches cross-border campaign to recruit clinical scientists and biotechnology industry executives](https://oicr.on.ca/wp-content/uploads/2016/05/facit-feature.jpg)
FACIT launches cross-border campaign to recruit clinical scientists and biotechnology industry executives
Aug 01, 2017
![FACIT announces investment in three Ontario start-ups under Prospects Fund](https://oicr.on.ca/wp-content/uploads/2017/08/Prospect_startups.jpg)
FACIT announces investment in three Ontario start-ups under Prospects Fund
Mar 22, 2017
![FACIT Launches The Prospects Oncology Fund](https://oicr.on.ca/wp-content/uploads/2017/01/prospects-oicr.jpg)
FACIT Launches The Prospects Oncology Fund
Mar 22, 2017
![FACIT Announces Investment in Propellon Therapeutics](https://oicr.on.ca/wp-content/uploads/2017/03/Propellon-knockout.png)
FACIT Announces Investment in Propellon Therapeutics
Feb 23, 2017
![FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation](https://oicr.on.ca/wp-content/uploads/2017/02/oicrfacit_trimmed.jpg)
FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation
Nov 02, 2016
![FACIT start-up Turnstone Biologics closes USD $41M financing](https://oicr.on.ca/wp-content/uploads/2016/11/StojdlBellLichty-crop.jpg)
FACIT start-up Turnstone Biologics closes USD $41M financing
Oct 05, 2016
![From our Annual Report: Investing in the cure and the economy](https://oicr.on.ca/wp-content/uploads/2016/10/annual-report1.jpg)
From our Annual Report: Investing in the cure and the economy
Sep 27, 2016
![Annual report for the Ontario Institute for Cancer Research](https://oicr.on.ca/wp-content/uploads/2016/09/oicr-annual-report.jpg)
Annual report for the Ontario Institute for Cancer Research
Sep 19, 2016
![Open resource: How we’re making our research resources more accessible to the community](https://oicr.on.ca/wp-content/uploads/2016/09/crr-blog.jpg)
Open resource: How we’re making our research resources more accessible to the community
Jul 04, 2016
![FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight](https://oicr.on.ca/wp-content/uploads/2016/07/FACIT-Falcon-alt.jpg)
FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight
Jun 23, 2016
![Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers](https://oicr.on.ca/wp-content/uploads/2016/05/facit-feature.jpg)
Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers
Jun 07, 2016
![OICR attends BIO International 2016 in San Francisco](https://oicr.on.ca/wp-content/uploads/2016/06/bio-pic-1.jpg)
OICR attends BIO International 2016 in San Francisco
May 26, 2016
![Privacy Analytics Acquired by IMS Health](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
Privacy Analytics Acquired by IMS Health
Mar 16, 2016
![FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic](https://oicr.on.ca/wp-content/uploads/2016/03/fusion.jpg)
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Jan 28, 2016
![Trillium Therapeutics Acquires Fluorinov Pharma](https://oicr.on.ca/wp-content/uploads/2016/04/FACIT-square.jpg)
Trillium Therapeutics Acquires Fluorinov Pharma
Dec 29, 2015
![OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers](https://oicr.on.ca/wp-content/uploads/2016/04/FACIT-square.jpg)
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
Dec 16, 2015
![FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics](https://oicr.on.ca/wp-content/uploads/2016/11/facit.png)
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
Dec 08, 2015
![FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia](https://oicr.on.ca/wp-content/uploads/2017/02/OICR_FACIT.jpg)
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Dec 08, 2015
![FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia](https://oicr.on.ca/wp-content/uploads/2017/02/OICR_FACIT.jpg)
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Nov 09, 2015
![FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership](https://oicr.on.ca/wp-content/uploads/2016/04/turnstone.jpg)
FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership
Oct 28, 2015
![FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management](https://oicr.on.ca/wp-content/uploads/2017/01/turnstone-logo.jpg)
FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management
Jan 07, 2015
![Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers](https://oicr.on.ca/wp-content/uploads/2021/10/cliche.jpg)
Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.